{"entity":{"type":"insider","cik":"0001612903","url":"/insider/0001612903","json_url":"/insider/0001612903.json","name":"Anderson Thomas","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":6,"first":"2014-07-23","last":"2024-07-16","span_basis":"filed_date"},"name_variants":[{"name":"Anderson Thomas","source":"filing","n_filings":6,"first_seen":"2014-07-23","last_seen":"2024-07-16"}],"transactions":[{"id":3145063,"accession":"0001437749-24-022829","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-022829","line_url":"/filing/0001437749-24-022829#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001612903","owner_name":"Anderson Thomas","owner_display_name":"Anderson Thomas","owner_url":"/insider/0001612903","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.8065,"price_display":"6.81","price_state":"stated","total_value":68065.0,"total_display":"68,065.00","total_whole":"68,065","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-07-16","scope":"insider"},{"id":8128034,"accession":"0001437749-23-025312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-025312","line_url":"/filing/0001437749-23-025312#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001612903","owner_name":"Anderson Thomas","owner_display_name":"Anderson Thomas","owner_url":"/insider/0001612903","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.8764,"price_display":"4.88","price_state":"stated","total_value":48764.0,"total_display":"48,764.00","total_whole":"48,764","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-06","filed_date":"2023-09-06","scope":"insider"},{"id":3339643,"accession":"0001562180-16-003622","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-16-003622","line_url":"/filing/0001562180-16-003622#line-2","is_derivative":false,"issuer_cik":"0001597553","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001597553","owner_cik":"0001612903","owner_name":"Anderson Thomas","owner_display_name":"Anderson Thomas","owner_url":"/insider/0001612903","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":550000.0,"total_display":"550,000.00","total_whole":"550,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-15","filed_date":"2016-11-28","scope":"insider"},{"id":8166258,"accession":"0001562180-15-000660","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-15-000660","line_url":"/filing/0001562180-15-000660","is_derivative":false,"issuer_cik":"0001597553","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001597553","owner_cik":"0001612903","owner_name":"Anderson Thomas","owner_display_name":"Anderson Thomas","owner_url":"/insider/0001612903","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":67.0516,"price_display":"67.05","price_state":"stated","total_value":402309.6,"total_display":"402,309.60","total_whole":"402,310","shares_owned_after":2520.0,"shares_owned_after_display":"2,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-10","filed_date":"2015-08-11","scope":"insider","n_lines":3},{"id":8891995,"accession":"0001562180-15-000467","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-15-000467","line_url":"/filing/0001562180-15-000467","is_derivative":false,"issuer_cik":"0001597553","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001597553","owner_cik":"0001612903","owner_name":"Anderson Thomas","owner_display_name":"Anderson Thomas","owner_url":"/insider/0001612903","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":79.64672727272728,"price_display":"79.65","price_state":"stated","total_value":438057.0,"total_display":"438,057.00","total_whole":"438,057","shares_owned_after":7200.0,"shares_owned_after_display":"7,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-08","scope":"insider","n_lines":2},{"id":6322078,"accession":"0001209191-14-048702","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-048702","line_url":"/filing/0001209191-14-048702#line-1","is_derivative":false,"issuer_cik":"0001597553","issuer_name":"Sage Therapeutics, Inc.","issuer_ticker":"SAGE","issuer_name_source":null,"issuer_url":"/issuer/0001597553","owner_cik":"0001612903","owner_name":"Anderson Thomas","owner_display_name":"Anderson Thomas","owner_url":"/insider/0001612903","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":108000.0,"total_display":"108,000.00","total_whole":"108,000","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-23","filed_date":"2014-07-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434647","name":"ZEVRA THERAPEUTICS, INC.","url":"/issuer/0001434647","role":"Director","n_filings":2,"first_seen":"2023-09-06","last_seen":"2024-07-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001597553","name":"Sage Therapeutics, Inc.","url":"/issuer/0001597553","role":"Officer","n_filings":4,"first_seen":"2014-07-23","last_seen":"2016-11-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001612903","retrieved_at":"2026-08-25T04:17:15+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}